Re: TD Zenith Capital Corp | Grey Market : ZHCLF
in response to
by
posted on
Jul 17, 2020 02:21PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Got an email from Zenith. They're looking into it.